PULSE BIOSCIENCES, INC. (PLSE)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

11 annual periodsNewest to oldest
20252024202320222021202020192018201720162015
Revenue$350,000$0$0$700,000$1.4M$0
Research & development$44.7M$32.3M$27.8M$20.8M$28.6M$26.4M$25.0M$17.3M$9.6M$5.5M$2.2M
Operating expenses$50.0M$48.0M$38.0M$25.8M$9.6M$4.5M
Operating income−$76.9M−$56.3M−$43.6M−$58.1M−$63.0M−$50.0M−$48.0M−$37.5M−$25.6M−$9.5M−$4.5M
EBITDAderived−$75.9M−$55.1M−$42.4M−$56.7M−$61.9M−$48.9M−$46.8M−$36.2M−$24.6M−$8.8M−$3.8M
Net income−$72.8M−$53.6M−$42.2M−$58.5M−$63.7M−$49.9M−$47.0M−$37.5M−$25.6M−$9.5M−$2.8M
Basic EPSper diluted share-$1.08-$0.92-$0.85-$1.72-$2.28-$2.14-$2.26-$2.20-$1.73-$0.86-$0.37
Diluted EPSper diluted share-$2.28-$2.14-$2.26-$2.20-$1.73-$0.86-$0.37

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys33$32.08M disclosed value
Sells (SEC code S)18$6.60M disclosed value
51 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
May 11, 2026Form 4/ADUGGAN ROBERT WDirector,TenPercentOwnerBuyCommon Stock660.2K$19.69$13.00M48.37M
May 11, 2026Form 4/ALAVIOLETTE PAUL AChief Executive OfficerBuyCommon Stock15.0K$19.69$295.4K15.8K
May 11, 2026Form 4LAVIOLETTE PAUL AChief Executive OfficerBuyCommon Stock15.0K$19.69$295.4K15.0K
May 11, 2026Form 4DUGGAN ROBERT WDirector,TenPercentOwnerBuyCommon Stock660.2K$19.69$13.00M48.21M
Feb 18, 2026Form 4 · 10b5-1Danahy Kevin PatrickChief Commercial OfficerSellCommon Stock5.0K$23.64$118.2K43.3K